Viewing StudyNCT05204628



Ignite Creation Date: 2024-05-06 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 2:22 PM
Study NCT ID: NCT05204628
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-01-24
First Post: 2021-12-20

Brief Title: A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib
Sponsor: Xuanzhu Biopharmaceutical Co Ltd
Organization: Xuanzhu Biopharmaceutical Co Ltd

Conditions & Keywords Data

Conditions:
Name
Non-small Cell Lung Cancer
Keywords:
Name View
Crizotinib View
XZP-3621 View